| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-116 |
Sentence |
denotes |
Effect of mannose chain length on targeting of glucocerebrosidase for enzyme replacement therapy of Gaucher disease. |
| T1 |
0-116 |
Sentence |
denotes |
Effect of mannose chain length on targeting of glucocerebrosidase for enzyme replacement therapy of Gaucher disease. |
| T1 |
0-116 |
Sentence |
denotes |
Effect of mannose chain length on targeting of glucocerebrosidase for enzyme replacement therapy of Gaucher disease. |
| TextSentencer_T2 |
117-237 |
Sentence |
denotes |
Recombinant human glucocerebrosidase (imiglucerase, Cerezyme) is used in enzyme replacement therapy for Gaucher disease. |
| T2 |
117-237 |
Sentence |
denotes |
Recombinant human glucocerebrosidase (imiglucerase, Cerezyme) is used in enzyme replacement therapy for Gaucher disease. |
| T2 |
117-237 |
Sentence |
denotes |
Recombinant human glucocerebrosidase (imiglucerase, Cerezyme) is used in enzyme replacement therapy for Gaucher disease. |
